The test was developed by MiRXES in collaboration with the Singapore Gastric Cancer Consortium (SGCC), the Diagnostic Development (DxD) Hub of Singapore’s Agency for Science, Technology and Research (A*STAR), National University Hospital (NUH), and Tan Tock Seng Hospital (TTSH).
* CE IVD marked and approved for IVD use by Singapore’s Health Sciences Authority
1 , et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
GASTROClear microRNA test
GASTROClear test can be ordered by healthcare providers through MiRXES partner diagnostic labs
Tan Tock Seng Hospital (TTSH)
Molecular Diagnostic Lab (MDL)
National University Hospital (NUH)
Molecular Diagnosis Centre (MDC)